• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向敲除 T 细胞鞘氨醇 1 受体可改善链脲佐菌素诱导的糖尿病小鼠的心肌纤维化。

Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, South Dakota State University, Brookings, South Dakota, USA.

Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, California Northstate University, Elk Grove, California, USA.

出版信息

FASEB J. 2018 Oct;32(10):5426-5435. doi: 10.1096/fj.201800231R. Epub 2018 Apr 26.

DOI:10.1096/fj.201800231R
PMID:29698062
Abstract

Infiltration of T cells is associated with patients who have diabetes at an increased risk of heart attack. T-cell sphingosine 1-phosphate receptor 1 (S1P)-mediated signaling directs T-lymphocyte trafficking. Effects of T-cell S1P activation on cardiac fibrosis in a murine diabetic model remain to be explored. For this purpose, conditional T-cell S1P knockout (TS1PKO) mice generated by crossing S1pr mice with Lck-Cre mice were used in a model of streptozotocin-induced diabetic cardiomyopathy. The TS1PKO mice exhibited sustained deficiency of both CD4 and CD8 T cells in the blood. The TS1PKO vehicle control mouse hearts featured an altered phenotype characterized by increased myocardial fibrosis and reduced cardiac contractility under normal levels of glucose. Compared with littermate diabetic mice, TS1PKO diabetic mice had improved cardiac function and alleviated cardiac fibrosis detected after 11 wk of diabetic induction. Our results indicate that T-cell S1P signaling activation plays a dual role in the pathogenesis of cardiac fibrosis with respect to the levels of glucose: T-cell S1P activation exerts antifibrotic effects in normoglycemia but exacerbates fibrosis under hyperglycemia.-Abdullah, C. S., Jin, Z.-Q. Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice.

摘要

T 细胞浸润与糖尿病患者发生心脏病的风险增加有关。T 细胞鞘氨醇 1-磷酸受体 1(S1P)介导的信号转导指导 T 淋巴细胞的迁移。T 细胞 S1P 激活对糖尿病小鼠模型中心脏纤维化的影响仍有待探讨。为此,通过将 S1pr 小鼠与 Lck-Cre 小鼠杂交生成条件性 T 细胞 S1P 敲除(TS1PKO)小鼠,用于链脲佐菌素诱导的糖尿病心肌病模型。TS1PKO 小鼠在血液中持续缺乏 CD4 和 CD8 T 细胞。TS1PKO 载体对照小鼠心脏表现出改变的表型,其特征是在正常葡萄糖水平下心肌纤维化增加和心脏收缩力降低。与同窝对照糖尿病小鼠相比,TS1PKO 糖尿病小鼠在糖尿病诱导 11 周后心脏功能改善,心脏纤维化减轻。我们的结果表明,T 细胞 S1P 信号激活在心脏纤维化的发病机制方面与葡萄糖水平具有双重作用:T 细胞 S1P 激活在正常血糖水平下发挥抗纤维化作用,但在高血糖下会加重纤维化。-Abdullah,CS,Jin,Z-Q。靶向敲除 T 细胞 S1P 受体 1 可改善链脲佐菌素诱导的糖尿病小鼠的心脏纤维化。

相似文献

1
Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice.靶向敲除 T 细胞鞘氨醇 1 受体可改善链脲佐菌素诱导的糖尿病小鼠的心肌纤维化。
FASEB J. 2018 Oct;32(10):5426-5435. doi: 10.1096/fj.201800231R. Epub 2018 Apr 26.
2
Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy.T淋巴细胞耗竭可改善链脲佐菌素诱导的糖尿病性心肌病中的心脏纤维化。
Int Immunopharmacol. 2016 Oct;39:251-264. doi: 10.1016/j.intimp.2016.07.027. Epub 2016 Aug 3.
3
Inhibition of PKC-θ preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy.PKC-θ 抑制可保护心脏功能并减少链脲佐菌素诱导的糖尿病心肌病中的纤维化。
Br J Pharmacol. 2014 Jun;171(11):2913-24. doi: 10.1111/bph.12621.
4
Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development.心肌细胞中的1-磷酸鞘氨醇受体-1是正常心脏发育所必需的。
Dev Biol. 2016 Oct 1;418(1):157-165. doi: 10.1016/j.ydbio.2016.06.024. Epub 2016 Jun 19.
5
Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice.白介素-17 消融通过抑制长链非编码 RNA-AK081284 减轻糖尿病小鼠心脏间质纤维化并改善心功能。
J Mol Cell Cardiol. 2018 Feb;115:64-72. doi: 10.1016/j.yjmcc.2018.01.001. Epub 2018 Jan 3.
6
Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.硫氧还蛋白相互作用蛋白的缺失改善链脲佐菌素诱导的糖尿病心脏的心脏变力性储备。
Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1748-59. doi: 10.1152/ajpheart.00051.2016. Epub 2016 Apr 1.
7
Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines.淋巴细胞功能的1型鞘氨醇-1-磷酸G蛋白偶联受体信号传导需要其细胞外氨基末端酪氨酸的硫酸化。
FASEB J. 2005 Nov;19(13):1926-8. doi: 10.1096/fj.05-4476fje. Epub 2005 Sep 7.
8
KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.KRP-203,鞘氨醇 1-磷酸受体 1 激动剂,改善 LDL-R-/- 小鼠的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1505-12. doi: 10.1161/ATVBAHA.113.301347. Epub 2013 May 2.
9
Sphingosine-1-Phosphate Receptor 1 Is Involved in Non-Obese Diabetic Mouse Thymocyte Migration Disorders.鞘氨醇-1-磷酸受体 1 参与非肥胖型糖尿病小鼠胸腺细胞迁移障碍。
Int J Mol Sci. 2018 May 12;19(5):1446. doi: 10.3390/ijms19051446.
10
Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.心肌成纤维细胞中增强的1-磷酸鞘氨醇受体-1信号传导通过血管紧张素II和白细胞介素-6诱导心肌肥大和纤维化。
PLoS One. 2017 Aug 3;12(8):e0182329. doi: 10.1371/journal.pone.0182329. eCollection 2017.

引用本文的文献

1
Identification of metabolic pathways and serum biomarkers in diabetic cardiomyopathy using untargeted metabolomics.使用非靶向代谢组学鉴定糖尿病性心肌病中的代谢途径和血清生物标志物
Sci Rep. 2025 May 28;15(1):18718. doi: 10.1038/s41598-025-98753-y.
2
Sphingosine-1-phosphate in the regulation of diabetes mellitus: a scientometric study to an in-depth review.1-磷酸鞘氨醇在糖尿病调节中的作用:一项深入综述的科学计量学研究
Front Endocrinol (Lausanne). 2024 Dec 24;15:1377601. doi: 10.3389/fendo.2024.1377601. eCollection 2024.
3
Cardiac fibrogenesis: an immuno-metabolic perspective.
心脏纤维化形成:免疫代谢视角
Front Physiol. 2024 Mar 21;15:1336551. doi: 10.3389/fphys.2024.1336551. eCollection 2024.
4
Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭伴高血压左心室肥厚患者的血液免疫细胞改变
J Cardiovasc Dev Dis. 2023 Jul 20;10(7):310. doi: 10.3390/jcdd10070310.
5
Identification of hub genes and potential ceRNA networks of diabetic cardiomyopathy.鉴定糖尿病心肌病的枢纽基因和潜在 ceRNA 网络。
Sci Rep. 2023 Jun 24;13(1):10258. doi: 10.1038/s41598-023-37378-5.
6
T cells and their products in diabetic kidney disease.糖尿病肾病中的 T 细胞及其产物。
Front Immunol. 2023 Jan 26;14:1084448. doi: 10.3389/fimmu.2023.1084448. eCollection 2023.
7
Role of resveratrol in inhibiting pathological cardiac remodeling.白藜芦醇在抑制病理性心脏重塑中的作用。
Front Pharmacol. 2022 Sep 1;13:924473. doi: 10.3389/fphar.2022.924473. eCollection 2022.
8
Dedifferentiation of Human Cardiac Myofibroblasts Is Independent of Activation of COX-2/PGE Pathway.人心脏成纤维细胞去分化不依赖 COX-2/PGE 通路激活。
Int J Mol Sci. 2022 Mar 11;23(6):3023. doi: 10.3390/ijms23063023.
9
Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.综述文章:鞘氨醇 1 磷酸/鞘氨醇 1 磷酸受体轴——炎症性肠病的独特治疗靶点。
Aliment Pharmacol Ther. 2022 Feb;55(3):277-291. doi: 10.1111/apt.16741. Epub 2021 Dec 21.
10
Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.糖尿病性心肌病的纤维化:临床意义、分子机制及治疗前景
Adv Drug Deliv Rev. 2021 Sep;176:113904. doi: 10.1016/j.addr.2021.113904. Epub 2021 Jul 29.